Uploaded December 2025 | Updated September 2026, 2 hours ago
Amy Berger takes on the world of “biohacking” and keto tracking culture, arguing that data and devices can either empower people or quietly wreck their mental health. She walks through how tools like CGMs, ketone meters, weight scales, and meticulous food logging can genuinely help assess progress, validate dietary changes, and guide future tweaks—when used in context. At the same time, she highlights stories of people driven into fear, confusion, and paralysis by conflicting influencers, extreme rules, and obsession with “perfect” numbers, coining her motto of “keto without the crazy” as a response. Throughout, she makes the case that keto, low carb, and carnivore should enlarge your life—not make it smaller—and calls on viewers to reassess the role of constant optimization, tracking, and social media in their health journey.
👉 Register at `https://cosci.org` for our coming CoSci 2026 at on March 13-15 in Las Vegas, NV. As with this presentation from 2025, you'll see great talks from Shawn Baker, Ken Berry, Amber O'Hearn, Nick Norwitz, Bret Scher and many, many more.
🎗️And best of all – CoSci is a charity event to support the Citizen Science Foundation, a 501(c)3 Public Charity supporting low carb/keto research like our #LMHR Study.
🫶 So you'll get to watch a great conference and support a good cause. Tickets start for as little as $25 – register now at `https://cosci.org`
⏱ Chapters
2:00 – Feldman inversion pattern & context
4:00 – Benefits of tracking and biohacking
6:26 – When numbers become your judge & jury
8:20 – Data as empowerment instead of fear
10:00 – APOE4, risk, and targeted action
12:04 – Getting lost in keto influencer noise
14:00 – “Ketoic” anxiety and fear of food
16:05 – Stressing over ketones vs living life
18:01 – Clickbait, hyperbole, and burned-out viewers
20:01 – Taking an “information vacation” from optimization
22:02 – Purging fear-based voices from your feed
24:44 – Reassessing tools, not abandoning keto
27:59 – Do you really need all this tracking?
29:12 – Final reminder: life first, wellness tools second
#AmyBerger #keto #lowcarb #biohacking #mentalhealth #nutrition #ketodiet #wellness #CoSci #CitizenScienceFoundation #LMHRStudy
Amy Berger takes on the world of “biohacking” and keto tracking culture, arguing that data and devices can either empower people or quietly wreck their mental health. She walks through how tools like CGMs, ketone meters, weight scales, and meticulous food logging can genuinely help assess progress, validate dietary changes, and guide future tweaks—when used in context. At the same time, she highlights stories of people driven into fear, confusion, and paralysis by conflicting influencers, extreme rules, and obsession with “perfect” numbers, coining her motto of “keto without the crazy” as a response. Throughout, she makes the case that keto, low carb, and carnivore should enlarge your life—not make it smaller—and calls on viewers to reassess the role of constant optimization, tracking, and social media in their health journey.
👉 Register at `https://cosci.org` for our coming CoSci 2026 at on March 13-15 in Las Vegas, NV. As with this presentation from 2025, you'll see great talks from Shawn Baker, Ken Berry, Amber O'Hearn, Nick Norwitz, Bret Scher and many, many more.
🎗️And best of all – CoSci is a charity event to support the Citizen Science Foundation, a 501(c)3 Public Charity supporting low carb/keto research like our #LMHR Study.
🫶 So you'll get to watch a great conference and support a good cause. Tickets start for as little as $25 – register now at `https://cosci.org`
⏱ Chapters
2:00 – Feldman inversion pattern & context
4:00 – Benefits of tracking and biohacking
6:26 – When numbers become your judge & jury
8:20 – Data as empowerment instead of fear
10:00 – APOE4, risk, and targeted action
12:04 – Getting lost in keto influencer noise
14:00 – “Ketoic” anxiety and fear of food
16:05 – Stressing over ketones vs living life
18:01 – Clickbait, hyperbole, and burned-out viewers
20:01 – Taking an “information vacation” from optimization
22:02 – Purging fear-based voices from your feed
24:44 – Reassessing tools, not abandoning keto
27:59 – Do you really need all this tracking?
29:12 – Final reminder: life first, wellness tools second
#AmyBerger #keto #lowcarb #biohacking #mentalhealth #nutrition #ketodiet #wellness #CoSci #CitizenScienceFoundation #LMHRStudy



![#CholesterolScience – with Ethan Weiss, MD
Hosted by Dave Feldman :: Produced by Siobhan Huggins
0:00 Intro and Ethan’s background
3:33 Cholesterol Skeptics and Concerned Medical Professionals – meeting in the middle.
( https://cholesterolcode.com/wp-content/uploads/2019/08/CholesterolScience-with-Ethan-Weiss.png )
8:20 How many patients does Ethan feel reach a decent level of knowledge about lipidology and cardiology?
10:15 Navigating the discussion on the benefits/risks of lipid changes from diet
17:15 When cholesterol is elevated for a metabolic reason alone – does it pose a greater risk?
( https://cholesterolcode.com/wp-content/uploads/2019/08/CholesterolScience-with-Ethan-Weiss-1.png )
( https://cholesterolcode.com/wp-content/uploads/2019/08/key-question.png )
23:00 Giving doctors the benefit of the doubt – are doctors just trying to help?
27:10 Dave’s disappointment with perceived lack of curiosity from the medicalsphere.
30:15 The difficulty in discussing possible benefits from lipoproteins and potential influence on all-cause mortality
36:50 Nuances of data collection and statin trials
- Study mentioned: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)09327-3/fulltext
Note from producer:
In the efficacy and safety statement for the trial mentioned it lists Merck Sharp & Dohme (manufacturers of simvastatin) as well as Hoffmann-La Roche (manufacturers of the vitamins used) as providing partial funding for the study:
The study is being funded by the UK Medical Research Council, the British Heart Foundation, Merck Sharp & Dohme (manufacturers of simvastatin[…]) and Hoffmann-La Roche (manufacturers of the vitamins[…]) https://doi.org/10.1053/euhj.1998.1350
- However in the published paper of the results it states the following:
The Clinical Trial Service Unit has a staff policy of not accepting honoraria or other payments from the pharmaceutical industry, except for the reimbursement of costs to participate in scientific meetings. https://doi.org/10.1016/S0140-6736(02)09327-3
44:56 If there were a trial that showed that people with high HDL, high LDL, and low triglycerides didn’t benefit from statins would [Ethan] want to know that information? (https://twitter.com/erreyedoc/status/1162070100037574656)
- Study mentioned: Influence of Low High-Density Lipoprotein Cholesterol and Elevated Triglyceride on Coronary Heart Disease Events and Response to Simvastatin Therapy in 4S https://www.ahajournals.org/doi/full/10.1161/hc5001.100624
52:40 Open data, machine learning, and possibilities moving forward
56:20 Non-HDL and mortality from the NHANES dataset
https://twitter.com/DaveKeto/status/1133177415486693376?s=20
58:30 Changes in ability to connect with researchers and scientists
1:00:05 What does Dave mean by risk?
1:04:10 Modifications to low carb to achieve lower LDL
1:08:55 What Dave has learned about the importance of rigorousness in self-experimentation
1:13:29 Can self-experiments have benefits applicable to people beyond the person doing them?
1:17:29 Cholesterol biosynthesis
1:18:40 Reverse causality – is there a possibility that the lipoproteins are reflecting a problem and not causing it?
Note from producer: I attempted a follow-up to see if I could find any studies looking at the impact of infusion of native mouse lipoproteins on atherosclerosis development, but I have not found any thus far.
1:24:33 Clotting, vascular injury, and engineering
1:29:55 The impact of placebo
Podcast mentioned: The Hidden Brain: The Untapped Potential of Placebos to Heal (transcript available) https://www.npr.org/2019/04/29/718227789/all-the-worlds-a-stage-including-the-doctor-s-office
1:33:23 The impact of seeing lipids change – could this impact the results of the study?
1:35:56 If it were dose dependency would all drugs that lower LDL have a likewise decrease in cardiovascular disease mortality?
1:38:46 Drug trials – ideals, replication, and funding
1:42:35 Wrap up and outro
Ethan Weiss Contact:
Twitter: @ethanjweiss #CholesterolScience – with Ethan Weiss, MD](https://i.ytimg.com/vi/phfHRZ_aME8/mqdefault.jpg)






